John M Humphrey

ORCID

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 9

Top Venues

The Journal of organic chemistry

Journal of medicinal chemistry

Organic letters

Pfizer Global Research and Development

University of California Irvine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pfizer Global Research and Development Jul 28 1998

United States

Associate Research Fellow :: Neuroscience Discovery Chemistry

Education History

University of California Irvine

United States

PHD :: Chemsitry

University of Michigan Flint

United States

BSC :: Chemistry

Publications

Yuan Zhang, Jack Chang Hung Lee, Matthew R Reese, Brian P Boscoe, John M Humphrey, Christopher J Helal
5-Aryltetrazoles from Direct C-H Arylation with Aryl Bromides. The Journal of organic chemistry 85 (8) (2020)
Longfei Xie, Christopher W Am Ende, Martin Pettersson, Danica A Rankic, Neal W Sach, Subbas Sakya, John M Humphrey
Synthesis of Pyridopyrazine-1,6-dione γ-Secretase Modulators via Selective 4-Methylimidazole N1-Buchwald Arylation. The Journal of organic chemistry 84 (8) (2019)
Paramita Mukherjee, Cristian P Woroch, Leah Cleary, Mark Rusznak, Ryan W Franzese, Matthew R Reese, Joseph W Tucker, John M Humphrey, Sarah M Etuk, Sabrina C Kwan, Christopher W Am Ende, Nicholas D Ball
Sulfonamide Synthesis via Calcium Triflimide Activation of Sulfonyl Fluorides. Organic letters 20 (13) (2018)
Christopher J Helal, Eric Arnold, Tracey Boyden, Cheng Chang, Thomas A Chappie, Ethan Fisher, Mihaly Hajos, John F Harms, William E Hoffman, John M Humphrey, Jayvardhan Pandit, Zhijun Kang, Robin J Kleiman, Bethany L Kormos, Che-Wah Lee, Jiemin Lu, Noha Maklad, Laura McDowell, Dina McGinnis, Rebecca E O'Connor, Christopher J O'Donnell, Adam Ogden, Mary Piotrowski, Christopher J Schmidt, Patricia A Seymour, Hirokazu Ueno, Nichole Vansell, Patrick R Verhoest, Edward X Yang
Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate. Journal of medicinal chemistry 61 (3) (2018)
Ethan L Fisher, Christopher W Am Ende, John M Humphrey
2,2,2-Trifluoroethoxy Aromatic Heterocycles: Hydrolytically Stable Alternatives to Heteroaryl Chlorides. The Journal of organic chemistry 84 (8) (2018)
Hua Zhou, Paramita Mukherjee, Rongqiang Liu, Edelweiss Evrard, Dianpeng Wang, John M Humphrey, Todd W Butler, Lise R Hoth, Jeffrey B Sperry, Sylvie K Sakata, Christopher J Helal, Christopher W Am Ende
Introduction of a Crystalline, Shelf-Stable Reagent for the Synthesis of Sulfur(VI) Fluorides. Organic letters 20 (3) (2018)
John M Humphrey, Matthew Movsesian, Christopher W Am Ende, Stacey L Becker, Thomas A Chappie, Stephen Jenkinson, Jennifer L Liras, Spiros Liras, Christine Orozco, Jayvardhan Pandit, Felix F Vajdos, Fabrice Vandeput, Eddie Yang, Frank S Menniti
Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1. Journal of medicinal chemistry 61 (10) (2018)
Danica A Rankic, Cory M Stiff, Christopher W Am Ende, John M Humphrey
Protocol for the Direct Conversion of Lactones to Lactams Mediated by 1,5,7-Triazabicyclo[4.4.0]dec-5-ene: Synthesis of Pyridopyrazine-1,6-diones. The Journal of organic chemistry 82 (23) (2017)
Lei Zhang, Laigao Chen, Elizabeth M Beck, Thomas A Chappie, Richard V Coelho, Shawn D Doran, Kuo-Hsien Fan, Christopher J Helal, John M Humphrey, Zoe Hughes, Kyle Kuszpit, Erik A Lachapelle, John T Lazzaro, Chewah Lee, Robert J Mather, Nandini C Patel, Marc B Skaddan, Simone Sciabola, Patrick R Verhoest, Joseph M Young, Kenneth Zasadny, Anabella Villalobos
The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging. Journal of medicinal chemistry 60 (20) (2017)

John M Humphrey.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

John M Humphrey